Terms: = Ovarian cancer AND hCG AND Clinical Outcome
3 results:
1. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract] [Full Text] [Related]
2. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.
Xue WC; Guan XY; Ngan HY; Shen DH; Khoo US; Cheung AN
Cancer; 2002 Apr; 94(8):2288-94. PubMed ID: 12001129
[TBL] [Abstract] [Full Text] [Related]
3. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
Mannaerts B; Gordon K
Hum Reprod; 2000 Sep; 15(9):1882-3. PubMed ID: 10966979
[TBL] [Abstract] [Full Text] [Related]
